Periplocoside A prevents experimental autoimmune encephalomyelitis by suppressing IL-17 production and inhibits differentiation of Th17 cells
- 13 July 2009
- journal article
- Published by Springer Nature in Acta Pharmacologica Sinica
- Vol. 30 (8) , 1144-1152
Abstract
Aim: Methods: Results: Conclusion:Keywords
This publication has 40 references indexed in Scilit:
- IL‐17‐producing γδ T cellsEuropean Journal of Immunology, 2009
- IL-17A and IL-17F do not contribute vitally to autoimmune neuro-inflammation in miceJournal of Clinical Investigation, 2008
- IL-6 blockade inhibits the induction of myelin antigen-specific Th17 cells and Th1 cells in experimental autoimmune encephalomyelitisProceedings of the National Academy of Sciences, 2008
- IL-12– and IL-23–modulated T cells induce distinct types of EAE based on histology, CNS chemokine profile, and response to cytokine inhibitionJournal of Experimental Medicine, 2008
- Retinoic acid inhibits Th17 polarization and enhances FoxP3 expression through a Stat-3/Stat-5 independent signaling pathwayBlood, 2008
- Rapamycin inhibits differentiation of Th17 cells and promotes generation of FoxP3+ T regulatory cellsInternational Immunopharmacology, 2007
- TH-17 cells in the circle of immunity and autoimmunityNature Immunology, 2007
- Interleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17–producing T cellsNature Immunology, 2006
- The IL-23/IL-17 axis in inflammationJournal of Clinical Investigation, 2006
- Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cellsNature, 2006